|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 283, Issue 1, 506-517, January 4, 2008
Molecular Analysis and Characterization of Zebrafish Keratocan (zKera) Gene*![]() ![]() ![]() ![]() ![]()
From the
Received for publication, September 12, 2007
Corneal small leucine-rich proteoglycans play a pivotal role in maintaining corneal transparency and function. In this study, we isolated and characterized the zebrafish (Danio rerio) keratocan (zKera) gene. The human keratocan sequence was used to search zebrafish homologues. The zKera full-length genomic DNA and cDNA were generated via PCR of zebrafish genomic DNA and reverse transcription-PCR of total zebrafish eye RNA, respectively. The zKera spanning 3.5 kilobase pairs consists of two exons and one intron and a TATA-less promoter. The zKera encodes 341 amino acids with 59% identity to its human counterpart and 57% identity to that of mouse keratocan. Like mouse and chick keratocan, zKera mRNA is selectively expressed in the adult cornea; however, during embryonic development, zKera mRNA is expressed in both the brain and the cornea. Interestingly, it is expressed mainly in corneal epithelium but also in the stroma. A pseudogene was proved by introducing a zKera promoter-driven enhanced green fluorescence protein reporter gene into fertilized zebrafish eggs. Using morpholino-antisense against zKera to knock down zKera resulted in a lethal phenotype due to massive caspase-dependent apoptosis, which was noted by a significant increase of active caspase-3 and caspase-8 in the developing forebrain area, including the eyes. This is different from mouse, for which keratocan-deficient mice are viable. Taken together, our data indicate that mammalian keratocan is conserved in zebrafish in terms of gene structure, expression pattern, and promoter function.
Keratocan, lumican, and mimecan/osteoglycin are extracellular keratan sulfate proteoglycans (KSPGs)4 belonging to the small leucine repeat proteoglycan (SLRP) family. These molecules fold into a horseshoe-shaped structure and bind to collagen molecules, facilitate formation of uniform collagen fibril diameters and interfibrillar spacing in extracellular matrix, modulate hydration of corneal stroma, and regulate corneal transparency (1-3). Unlike lumican and mimecan, which are expressed in various tissues, keratocan gene expression is much more restricted to the cornea in adult mice (4). So far, only keratocan has been shown to be directly associated with an inherited human disease, cornea plana, that manifests itself via reduced visual acuity, a flattened corneal curvature, corneal parenchymal opacity, and a thin corneal stroma (5). It has been shown that the similar phenotype of a flattened corneal curvature, as well as a thin corneal stroma, is present in keratocan knock-out mice (6), suggesting that this mouse line can serve as a model of corneal plana.
Zebrafish is a popular vertebrate model to study the biology and molecular genetics of development (7-11). Transgenic technology is a powerful tool for studying gene functions via strategies of gain of function and/or dominant negative mutations. In the zebrafish model, tissue-specific promoters have been examined with enhanced green fluorescence protein (EGFP) reporter gene (7). In addition, the transgenic zebrafish model provides advantages (e.g. shorter embryonic development time) (72 h), and transparent embryos allow easy observation with an optical device and easier treatment schemes in comparison with transgenic mice. In eye research, zebrafish have been proven an excellent model system for retinal development, degeneration, and glaucoma study; however, few corneal studies have been undertaken (8, 9, 12). Zebrafish have transparent corneas, implying that KSPGs may also play a significant role in regulating corneal transparency in the zebrafish similar to what has been described in mammals. In this study, we take the first step toward the possibility of using zebrafish as a model system for corneal development and disease. The ultrastructure of zebrafish corneal tissue is studied by transmission electron microscopy. We also characterize the zebrafish Kera gene and its expression pattern in adults and during embryonic development. To investigate, the functionality of the zebrafish Kera promoter, we have employed 1.7- and 1.3-kb genomic DNA fragments 5' of zKera to drive the EGFP reporter gene in zebrafish via transgenic approaches. Furthermore, keratocan gene knockdown via morpholino-antisense resulted in embryonic lethality, which can be attributed in part to a significant increase in the level of caspase-dependent apoptosis in the brain. The observation suggests that zKera may have a critical function(s) for normal zebrafish development other than serving as a regulatory molecule of extracellular matrix formation.
Maintenance of Zebrafish Raising, maintaining, and spawning of adult zebrafish were performed as described in Ref. 13. Adult zebrafish and embryos were maintained at 28.5 °C on a 14-h light and 10-h dark cycle. All procedures were approved by the Institutional Animal Care and Use Committee of National Taiwan University.
Isolation and Characterization of zKera cDNA and Genomic DNA
5'-RACE
Generation of Transgenic Zebrafish by zKera Promoter-driven EGFP
Sequence Alignment and Phylogenetic Analysis
Northern Blotting Hybridization
RT-PCR
In Situ Hybridization (Whole Mount and Sectioned Corneal Tissue)
Preparation of an Epitope-specific Polyclonal Anti-zebrafish Keratocan Antibody
Immunoblotting and SDS-PAGE
Immunohistochemistry
Transmission Electron Microscopy
Preparation and Microinjection of Morpholino-antisense Oligonucleotides Antisense MOs (Gene Tools, Philomath, OR) were designed to target at the 5'-untranslated region or flanking region, including the initiation codon of the respective genes. The MO sequence was as follows: zKera-MO, 5'-AATGCTACCAAGAGTACCTCCATAG. This oligonucleotide complements the sequence from -2 through +23 relative to the initiation codon. A random sequence (RS) MO served as a control for zKera-MO: 5'-CCTCTTACCTCAGTTACAATTTATA-3'. This MO is offered by Gene Tools as a negative control oligonucleotide that should have no target specificity. A search of the data base did not identify any sequence similarity to known zebrafish genes with the zKera-MO. Solutions were prepared and injected at the 1-4-cell stage as described (16). Injected embryos were maintained at 28 °C until analyzed.
Apoptosis Assays
Caspase-3, Caspase-8, and Mitochondrial Apoptosis—To detect active caspase enzymes and loss of mitochondrial membrane potential during apoptosis, the image-iT LIVE Green caspase-3 and -7 detection kit, image-iT LIVE Green caspase-8 detection kit, and MitoTracker Red CMXRos (Molecular Probes, Inc., Eugene, OR) were performed in live embryos according to the manufacturer's instructions. Briefly, samples were incubated in 1x FLICA reagent working solution for 30 min and protected from light. Thereafter, samples were washed with 1x wash buffer and observed under a fluorescent microscopy.
Primary Structure of the zKera Gene and Comparison of Deduced Amino Acid Sequence of Zebrafish Keratocan with Other Species—We identified the zKera gene by performing a BLAST search of the publicly available zebrafish data bases against the human KERA gene. The entire DNA sequence of the zKera gene is shown in Fig. 1. As illustrated in Figs. 1 and 2A, the entire DNA sequence of the zKera gene spans 3.5 kb (3589 bp) and contains two exons, one intron, and the promoter region. Comparing DNA sequence from the cDNA and the genomic DNA of the zKera gene, we found that exon 1 is 1373 bp and encodes an N-terminal domain and central leucine-rich repeats, and exon 2 contains 161 bp of coding sequence and 138 bp of 3'-untranslated sequence. The transcription initiation site marked +1 was determined via 5'-RACE as described under "Experimental Procedures." The first translation initiation ATG codon is located at the 511th base from the beginning of exon 1. Therefore, exon 1 contains 511 bp of 5'-untranslated sequence. There is no TATA consensus sequence found in the 2.2 kb of the proximal 5'-flanking region of the zKera gene, which was utilized as the promoter region. The cDNA clone ( 1.9 kb) contains a 1023-bp open reading frame encoding zebrafish keratocan (341 amino acid (aa) residues). Like other SLRP core proteins (i.e. lumican (17), mimecan (18), and keratocan (4), zebrafish keratocan shows three distinct domains: a highly conserved central leucine-rich repeat region, flanked by hypervariable N- and C-terminal regions (Fig. 1). As shown in Fig. 1, after the signal peptide (Met-His; the first 20 aa), the N-terminal region contains a consensus YE motif for protein sulfation, which indicates the possible presence of sulfotyrosine(s) in zKera (19). A central leucine-rich domain contains ten tandem repeats of the sequence LXXLXLXXNX(L/I). In addition, another genomic DNA sequence similar to the normal zKera gene with a 724-bp deletion from bp -690 to +34 was identified by different primer pairs, suggesting that there is a pseudogene of Kera that does not have an open reading frame and is designated as zKera' in the zebrafish genome (Fig. 2, A and B). The zKera genomic DNA was subcloned and characterized by Southern blot hybridization, PCR, and DNA sequencing (data not shown). We have isolated clones representing the full open reading frame of zebrafish keratocan. A cDNA clone encoding the keratocan open reading frame was subcloned into the pBluescript SK vector (Stratagene, La Jolla, CA). The open reading frame of the zKera gene was 1023 bp long and encoded 341 amino acid residues.
For bioinformatics analysis in the promoter region, putative transcription factor binding sites were searched using the "TFSEARCH" program (available on the World Wide Web) with threshold score (default: 95.0). The results revealed several transcription factor-binding elements in the 2.2-kb (-1700 to +510) 5'-flanking region of the zKera gene. A MyoD binding site, agacaggtgttg (-1584 to -1573), a CdxA binding site, aataata (-857 to -851), a C/EBPa binding site, atattgcaaaatga (-735 to -722), a GATA-1 binding site, agcagataaggag (-243 to -231), a GATA-X binding site, agataagaatt (+29 to +39), a CREB binding site, tgacgtct (+388 to +395), and a CdxA binding site, attaata (+443 to +449), are arranged in a sense direction to the zKera gene. One Nkx-2 binding site, cacttaa (+201 to +207), one CdxA binding site, tattaat (+442 to +448), one Sox-5 binding site, atattgt (+447 to +452), and one Oct-1 binding site, taacatctcattttg (+454 to +468), are found in an antisense direction to the zKera gene. Analysis of zKera Promoter Activity in Transgenic Zebrafish—To confirm the zKera gene that we isolated is a functional gene, we prepared two reporter gene constructs, zKerapr1.7-EGFP-SV40 and zKera pr1.3-EGFP-bpA, for microinjection into the one-cell stage of fertilized zebrafish eggs. Live transgenic EGFP-positive embryos were screened and selected under a fluorescent microscope. Eighty-two percent of injected embryos continued developing, with 93% of them hatching and over 75% surviving beyond 12 days postfertilization (dpf). In transgenic zebrafish, 33.25% (n = 411) of the 1.7-kb zKera promoter fragment-injected embryos expressed the EGFP transgene restricted to the eye (Fig. 2, C, F, and G), whereas the 1.3-kb promoter fragment of the zKera gene-injected embryos shows nearly undetectable low levels of EGFP expression in all zebrafish (n = 401) (Fig. 2, D and H). The deletion of the 5' 0.4 kb of sequence had an effect on the efficiency of EGFP expression and was likely to contain regulatory elements of importance. On the other hand, the second zKera gene similar to the normal zKera gene with a 724-bp deletion (Fig. 2, A, B, and E) could not drive EGFP cDNA expression in transgenic zebrafish (Fig. 2, E and I), suggesting that this is a zKera pseudogene. For comparison, multiple alignment analysis of the predicted amino acid sequences of zKera with that of other species was shown in Fig. 3A. To examine the evolutionary relationship between different species, we conducted a phylogenetic tree based on unspliced primary sequences of the zKera (Fig. 3B). The predicted amino acid sequences of these proteins showed a high homology to known Kera protein of other species. zKera exhibits a 59% amino acid sequence identity to human keratocan while exhibiting 57% amino acid sequence identity to mouse keratocan.
Expression of the mRNA Encoding the Zebrafish Keratocan—Northern blot hybridization was performed to compare the relative amounts of zKera mRNA in the adult zebrafish cornea and other tissues. Electrophoretically separated total RNA from various parts of adult zebrafish tissue were transferred to membranes and probed with zKera cDNA. Ethidium bromide staining of 28 and 18 S rRNA served as loading controls. Fig. 4A showed that zKera mRNA is a
Spatial Distribution of mRNA Encoding the Keratocan Protein in the Zebrafish—In order to determine the spatial pattern of keratocan expression during zebrafish development, whole mount in situ hybridization with antisense riboprobes was performed. Whole mount in situ revealed that zKera mRNA was expressed in the eyes and the major subdivisions of the embryonic central nervous system, including the fore-, mid-, and hindbrain, and the anterior spinal cord at 2 dpf (Fig. 5, A-C). The expression pattern of zKera mRNA at 3 dpf was similar to the pattern at 2 dpf. Interestingly, there is a specific localization pattern expressed in the corneal epithelial layer in the adult zebrafish (Fig. 5, E and G). The corresponding sense riboprobes showed negligible staining in samples serving as negative controls (Fig. 5, D, F, and H). Western Blotting and Immunohistochemistry—To detect zebrafish keratocan, we generated an affinity-purified antibody against a synthetic peptide corresponding to the 18 N-terminal amino acid residues deduced from the zKera cDNA. To compare zebrafish keratocan with mammalian keratocan, total lysates from human, mouse, and zebrafish eyes, respectively, were treated with or without endo-β-galactosidase and keratanase and then subjected to Western blot analysis. Fig. 6 shows a smearing pattern (lanes 1, 3, and 7) in human, mouse, and eye tissue without endo-β-galactosidase digestion and one band (lanes 2, 4, and 8) with endo-β-galactosidase digestion. In addition, adult zebrafish corneal proteins extracted by lysis buffer and probed with the antibody against keratan sulfate showed the similar smearing pattern without keratanase digestion (lane 5), whereas the smearing pattern disappeared after treatment with keratanase and proved to have keratan sulfate chains (lanes 6 and 9). Fish samples treated with endo-β-galactosidase (lane 8) and with keratanase (lane 9) showed the similar pattern. These data demonstrate that the zKera protein isolated from the eyes appears as a KSPG, which is similar to those of humans and mice. It has been shown that human and mouse keratocan is found at the corneal stromal layer (14). Interestingly, immunoreactivity to zKera was present mainly throughout all corneal epithelial layers (Fig. 7A), whereas only little was found in the corneal stroma. The increased immunoreactivity to zKera was found in the corneal stroma after endo-β-galactosidase digestion (Fig. 7B). Tissue sections probed with anti-keratan sulfate antibody after sections were treated without keratanase (Fig. 7C) and with keratanase (Fig. 7D) were used to prove that keratocan is a KSPG, especially in the corneal stroma. These results indicated that the keratan sulfate chain of zKera keratocan in cornea stroma could interfere with the binding of anti-keratocan antibody in immunohistochemistry. The keratocan in the whole mount staining showed a similar expression pattern of in situ hybridization (Fig. 7E). The negative control using preimmune rabbit IgG is shown in Fig. 7F. Hematoxylin and eosin stain was used to show the corneal structure (Fig. 7G), and 4,6-diamidino-2-phenylindole stain was used to show the cell nuclei. (Fig. 7H) Most cells were located mainly in the epithelial layer. No immunoreactivity was detected in the negative control sample (data not shown).
Ultrastructure of Adult Zebrafish Corneas—Electron microscopic examination was performed to analyze the ultrastructure of zebrafish cornea as shown in histograms (Fig. 7, I and J). The layer of epithelium is thicker than that of stroma. The epithelium contains only 3-4 cell layers. The endothelium comprises a single cell layer. Caspase-dependent Apoptosis Triggered by zKera Morpholino Oligonucleotide Injection—Keratocan knock-out mice exhibit a flattened corneal phenotype and a thin corneal stroma (6). This led us to examine the effects of keratocan depletion in zebrafish embryos. Western blot and RT-PCR were carried out to show that zKera protein and mRNA decreased after zKera-MO was injected (Fig. 8A, lane 3). However, zKera protein and mRNA did not decrease after RS-MO was injected (Fig. 8A, lane 2). Although there was no significant difference in gross morphology between zKera-MO, RS-MO, and wild type embryos, we found that the zKera-MO zebrafish embryos after microinjections with serial dilutions had higher mortality rates than RS-MO and wild type embryo groups (Fig. 8B). A higher mortality rate was first noticed in a 3-dpf embryo in the zKera-MO injected group (Fig. 8B). More significant differences were found at the 9 and 11 dpf embryo stage. Increased TUNEL-positive apoptotic cells were observed in whole mount embryos at 3 dpf after zKera-MO was injected (Fig. 8C). Many apoptotic cells were found throughout the head of zebrafish, particularly in the eye, forebrain, and midbrain, and a few scattered in the zebrafish body (Fig. 8C). Few apoptotic cells were found in RS-MO embryos (Fig. 8D). AO staining, a membrane-permeable aromatic derivative resulting fluorescent in acidic lysosomal vesicles for detecting apoptotic cells, showed increased numbers of AO-positive cells in zKera-MO embryos (Fig. 9A) than in the RS-MO (Fig. 9B) and wild type embryos (data not shown). Knockdown of keratocan did lead to increased levels of cell death, as determined by TUNEL assays and acridine orange staining on embryos derived from fertilized eggs injected with keratocan-specific morpholinos (Figs. 8C and 9A). This indicates that zKera is indispensable for the normal development of zebrafish. Caspase enzymes participate in a series of reactions that are triggered in response to proapoptotic signals and result in apoptosis. Based on a fluorescent inhibitor of caspases (FLICATM) methodology, we found that caspase-3-positive cells (Fig. 9E) and caspase-8-positive cells (Fig. 9G) were significantly increased in zKera-MO injected group in 3-dpf embryos. However, apoptotic cells were not detected by MitoTracker Red CMXRos staining due to no significant loss of mitochondrial membrane potential (Fig. 9C). Therefore, depletion of keratocan protein induces apoptosis through activated caspase-3 and -8 in zebrafish embryos. Taken together, our findings suggest that the phenotype caused by keratocan depletion can be attributed at least in part to a significant increase in the level of caspase-dependent apoptosis.
In this study, we isolated the zebrafish keratocan gene and examined its expression during development and in adults. Analysis of genomic clones suggests that the zebrafish genes in general do not contain introns. Zebrafish keratocan shared 59% amino acid identity with human keratocan and 57% amino acid identity with mouse keratocan. Interestingly, the size and structure of zKera is not similar to the mouse gene. Moreover, like mouse and bovine keratocan gene, the zKera promoter does not contain a conventional TATA box in the proximal promoter region; as a result, zKera is a TATA-less gene (4). Unlike the TATA-less promoters of housekeeping genes, the zKera promoter does not have a GC-rich sequence. The transcription factor binding motif in the 5'-flanking region of the zKera gene indicated several consensus-binding sites for various transcription factors. The identification of the 1.7-kb regulatory elements of the zKera gene is an important first step in elucidating regulatory mechanisms of keratocan during zebrafish development. Therefore, a functional analysis is needed to further determine cis-elements that contribute to zKera gene regulation.
Like mouse keratocan, zebrafish keratocan has all of the structural features of SLRPs (i.e. a central domain of leucinerich repeats flanked by N- and C-terminal domains with conserved cysteines) (20). Zebrafish keratocan gene contains 10 leucine-rich repeats in tandem and four and two cysteine residues at the amino and carboxyl terminus, respectively. From deduced amino acid sequences (Fig. 3A), we found that there are four possible sites (resides 95, 169, 224, and 262) for N-linked glycosylation in the domain of leucine-rich repeat among species other than zebrafish. In zebrafish keratocan, residues 95 and 262 in the deduced amino acid sequence of zKera contain the consensus NX(S/T) sequences for N-linked glycosylation. However, other amino acids substituted asparagines in residues 169 and 224. Therefore, only two potential N-linked glycosylation sites are available in zKera. Decorin, biglycan, and epiphycan have GAG attachment sites, which consist of a Ser-Gly pair preceded by acidic amino acid residues at the N-terminal end proximal to the cysteinerich region (21, 22). In contrast, lumican, keratocan, and fibromodulin have sulfotyrosine residues at the N-terminal end of the mature core proteins. The sulfated tyrosine may affect interactions with cationic domains of other extracellular matrix components and/or cell surface proteins. In zKera, residue 34 is the only putative tyrosine followed by an acidic amino acid (Glu) near the N terminus, a consensus sequence for tyrosine sulfation and there is no consensus sequence for an N-linked glycosylation site found in the N terminus. The effect of keratanase and endo-β-galactosidase digestion on corneal protein lysates indicates that the zebrafish keratocan contains keratan sulfate chain (Fig. 6, C (lane 6) and D (lanes 8 and 9)). The observations are consistent with the notion that N-linked glycosylation for keratan sulfate-GAG chain exists in zebrafish keratocan. The expression of keratan sulfate-keratocan in the fish stroma may preserve its function for a role in collagen fibrillogenesis, as has been suggested for mammals (e.g. mice and human beings). Moreover, keratocan is significantly expressed by zebrafish corneal epithelium, which contains little extracellular matrix and keratin sulfate if there is any. Thus, the zebrafish keratocan may have not yet defined functions other than serving as a regulatory molecule of collagen fibrillogenesis for the formation of characteristic corneal stromal extracellular matrix of uniform collagen fibril diameters and interfibril spacing. Further study is necessary to elucidate the physiological significance of zebrafish keratocan expression by corneal epithelium.
Keratocan is expressed almost exclusively in adult vertebrate cornea, whereas its embryonic expression has not yet been thoroughly examined in mammals. During chick embryonic development, the Kera gene is widely expressed in various embryonic tissues, including central nervous system and mesenchyme of connective tissues (23). In mice, Kera gene expression starts as early as embryonic day 13.5 by periocular mesenchymal cells of neural crest origin, which migrate toward the cornea and sclera and restrict to corneal keratocytes at embryonic day 18.5, at a time that is concurrent with the cessation of mesenchymal cell migration (4). Therefore, expression of Kera may serve as a specific marker of corneal stromal cells, and the application of a Kera promoter to drive heterologous transgenes in mice can be useful for studies of for corneal cell biology studies. It is of interest to note that, in the zebrafish 2-3 dpf larvae stage, keratocan is widely expressed in the brain in addition to in ocular tissue, whereas its expression is restricted to the corneal epithelial layer and stromal layer in the adult. Therefore, the zKera promoter is invaluable in preparing transgenic zebrafish lines to elucidate the mechanisms controlling corneal gene expression. In the present study, we identified a 1.7-kb zKera promoter and successfully generated transgenic zebrafish that showed a tissue-specific EGFP expression pattern that is similar to that of Kera. This promoter drove EGFP expression from embryonic through adult stages, suggesting that transcription factor binding sites within this 1.7-kb region are sufficient to confer cornea-specific expression in zebrafish. Our ongoing experiments are to characterize the promoter/enhancer region of zKera for the identification of minimal cis-regulatory DNA elements that confer cornea-specific expression in zebrafish using deletion mutants of the zKera promoter. Furthermore, tracking the expression of keratocan during zebrafish development via the use of transgenic zKera-EGFP fish will also shed light for a better understanding of the role of keratocan in this process. In this study, we showed that the Kera gene is expressed by corneal epithelial cells and stromal cells in adult zebrafish. The expression pattern of the zebrafish keratocan is much different from the expression pattern in the stromal layer in other species. Therefore, we can predict that the corneal epithelial cells in zebrafish may be more important in the maintenance of corneal transparency and structure. These findings also reveal an as yet unknown role of keratocan in maintaining corneal physiology. Further investigation needs to focus on the function of keratocan in corneal epithelial cells for a better understanding of the molecular basis of corneal epithelial development. In humans, mutations of the human KERA gene are associated with cornea plana (CNA2) in which the forward convex curvature of cornea is flattened, leading to a decrease in light refraction (5). In our previous study (6), Kera knock-out mice presented a thinner corneal stroma and a narrower cornea-iris angle of the anterior segment in comparison with the wild type littermates. For zebrafish, we show that antisense morpholino oligonucleotides are capable of down-regulating the expression of the zKera mRNA and reduction of zKera protein synthesis, which manifests with enhanced apoptosis and embryonic lethality (Fig. 8, B and C). Several investigators have reported that nonspecific effects of morpholino may induce widespread cell death and neural degeneration (16, 25, 26, 28). To prevent nonspecific effects of morpholino, embryos transfected with control oligonucleotides (RS-MO) and wild type embryos were prepared in our study. No significant morphological difference could be recognized between zKera-MO and RS-MO embryos at early developmental stages; a significantly higher mortality rate was noticed in the zKera-MO group (58.23%, 658 of 1130) than RS-MO embryos (30.64%, 201 of 656) and the wild type group (27.52%, 287 of 1043). Moreover, significant increases of apoptotic signals were prominent in the anterior part of the body, particularly in the eye and head of zKera-MO-injected embryos, whereas very few apoptotic signals were found in either RS-MO-injected or wild type embryos. This may be responsible for the increased mortality rate in zKera-MO-injected embryos. In addition, apoptosis induced by zKera-Mo injection went through the caspase-dependent pathway by the evidence of the activation of caspase-3 and caspase-8 enzymes in zebrafish (30, 31). The lack of detectable corneal phenotypes in morpholino-injected zebrafish embryos may be in part explained by the finding that expression of zKera was in part confined to the corneal epithelium; in contrast, mice keratocan knock-out exhibited thin corneas, since keratocan was primarily found in corneal stroma of mammals (6). Besides species differences, there are alternate explanations as to why zKera morpholino injection does not have a phenotype similar to that of keratocan knock-out mice. First, the zKera morpholino may not persist at concentrations higher enough to sustain continued inhibition of zKera core protein synthesis in adult zebrafish. Furthermore, the keratocan may not have a key role in regulating collage fibrillogenesis for the formation of stromal extracellular matrix. This hypothesis is substantiated by our finding that there was no significant difference in corneal thickness between these groups by transmission electron microscopy study (zKera-MO versus RS-MO versus wild type; data not shown). It is plausible to hypothesize that keratocan may have a function in cell survival by preventing apoptosis during embryonic development of zebrafish. "Gene sharing" has been proposed to explain the adaptation of gene usage by various species during evolution (29, 32-35). For example, Piatigorsky et al. (36, 37) studied lens crystallins and proposed the concept of "gene sharing" by which proteins can evolve new functions by changes in gene regulation in the absence of or before gene duplication without a change in protein structure. Other examples, such as Drosophila rhodopsin and xanthine oxidoreductase, also show that gene sharing is consistent with changes in gene regulation being an evolutionary driving force for innovation of protein function (24, 27, 37). Our results showed that the expression of zebrafish keratocan is not only in eyes but also in brains during development. Thus, it is possible that the loss and/or reduction of keratocan may have a detrimental impact on cell survival in the brain during development through the effect of gene sharing. As expected, brain cells may be sensitive to the decrease of keratocan, because the effect of "gene sharing" in the brain cells and a reduction of keratocan concentration may cause apoptosis in zKera-MO embryos, but this small change has little effect on corneal morphogenesis. This phenomenon is very different from previous studies in mice and suggests a novel role of keratocan; it has not yet been shown whether such cell survival functions also extend to other members of the SLRP family (e.g. lumican in zebrafish development). Collectively, these results show that the zebrafish Kera gene can serve as a specific marker for eye tissue and promise the potential use of the Kera promoter to drive heterologous transgenes in fish for studies in corneal biology. They also lead to the discovery of a novel function of the zKera in zebrafish.
The nucleotide sequence(s) reported in this paper has been submitted to the Gen-BankTM/EBI Data Bank with accession number(s) DQ667686.
* This work was supported in part by Taiwan National Science Council grants 923112B002004, 933112B002031, 943112B002007, 932314B002090, 942314B002043, and 94WHK0500128 and National Institutes of Health Grants RO1 EY 12486 (to C. Y. L.) and EY11845 (to W. W. Y. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Recipient of an Olga Weiss Scholarship from Research to Prevent Blindness.
2 An Research to Prevent Blindness senior investigator. 3 To whom correspondence should be addressed: Dept. of Ophthalmology, National Taiwan University Hospital, 7 Chug-Shan South Rd., Taipei 100, Taiwan. Tel.: 886-223123456 (ext. 5729); Fax: 886-223142875; E-mail: ijong{at}ha.mc.ntu.edu.tw.
4 The abbreviations used are: KSPG, keratan sulfate proteoglycan; SLRP, small leucine repeat proteoglycan; EGFP, epidermal growth factor; EST, expressed sequence tag; RACE, rapid amplification of cDNA ends; hpf, hours postfertilization; GFP, green fluorescent protein; RT, reverse transcription; DIG, digoxigenin; PBS, phosphate-buffered saline; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; MO, morpholino-antisense oligonucleotides; RS, random sequence; TUNEL, terminal deoxynucleotidyl transferase-mediated nick end-labeling; AO, acridine orange; aa, amino acid; KS, keratan sulfate.
We thank Chun-Wen Chen, Yu-Ching Wu, and Ting-Shuan Chiang for help throughout the course of this study and Dr. Wei-Hsuan Yu, Dr. Bei-En Chang, and Dr. Huey-Jen Tsay for critical comments on the manuscript.
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||